Structural and functional alterations in the colonic microbiome of the rat in a model of stress induced irritable bowel syndrome

Gut Microbes

Volumn 8, Issue 1, 2017, Pages 33-45

  Fourie, Nicolaas H ^a   Wang, Dan ^a   Abey, Sarah K ^a   Creekmore, Amy L ^b   Hong, Shuangsong ^b   Martin, Christiana G ^a   Wiley, John W ^b   Henderson, Wendy A ^a  

^a NATIONAL INSTITUTE OF NURSING RESEARCH   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

colon; microbiome; mucosa; stress; visceral hypersensitivity

Indexed keywords

RNA 16S;

ADULT; ANIMAL EXPERIMENT; ARTICLE; COLON FLORA; COLON MUCOSA; COMPUTER MODEL; CONTROLLED STUDY; DNA PURIFICATION; GENE AMPLIFICATION; HIGH THROUGHPUT SEQUENCING; IRRITABLE COLON; MALE; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL DIVERSITY; MICROBIOME; NONHUMAN; PROTEOBACTERIA; RAT; RNA SEQUENCE; SPECIES RICHNESS; STRESS; ANIMAL; BACTERIUM; CLASSIFICATION; COLON; DISEASE MODEL; GENETICS; HUMAN; INTESTINE FLORA; INTESTINE MUCOSA; ISOLATION AND PURIFICATION; MICROBIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BACTERIA; COLON; DISEASE MODELS, ANIMAL; GASTROINTESTINAL MICROBIOME; HUMANS; INTESTINAL MUCOSA; IRRITABLE BOWEL SYNDROME; MALE; METAGENOMICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 85009963236     PISSN: 19490976     EISSN: 19490984     Source Type: Journal    
DOI: 10.1080/19490976.2016.1273999     Document Type: Article

References (52)

1. Mayer EA, Collins SM. Evolving pathophysiologic models of functional gastrointestinal disorders. Gastroenterology 2002; 122:2032-48; PMID:12055608; http://dx.doi.org/10.1053/gast.2002.33584
2. Kalmokoff M, Franklin J, Petronella N, Green J, Brooks SP. Phylum level change in the cecal and fecal gut communities of rats fed diets containing different fermentable substrates supports a role for nitrogen as a factor contributing to community structure. Nutrients 2015; 7:3279-99; PMID:25954902; http://dx.doi.org/10.3390/nu7053279
3. Wos-Oxley ML, Bleich A, Oxley AP, Kahl S, Janus LM, Smoczek A, Nahrstedt H, Pils MC, Taudien S, Platzer M, et al. Comparative evaluation of establishing a human gut microbial community within rodent models. Gut Microbes 2012; 3:234-49; PMID:22572831; http://dx.doi.org/10.4161/gmic.19934
4. Jiminez JA, Uwiera TC, Inglis GD, Uwiera RR. Animal models to study acute and chronic intestinal inflammation in mammals. Gut Pathogens 2015; 7:1; PMID:25653718; http://dx.doi.org/10.1186/s13099-015-0076-y
5. Hong S, Fan J, Kemmerer ES, Evans S, Li Y, Wiley JW. Reciprocal changes in vanilloid (TRPV1) and endocannabinoid (CB1) receptors contribute to visceral hyperalgesia in the water avoidance stressed Rat. Gut 2009; 58:202-10; PMID:18936104; http://dx.doi.org/10.1136/gut.2008.157594
6. Hong S, Zheng G, Wu X, Snider NT, Owyang C, Wiley JW. Corticosterone mediates reciprocal changes in CB 1 and TRPV1 receptors in primary sensory neurons in the chronically stressed Rat. Gastroenterology 2011; 140:627-37.e4; PMID:21070780; http://dx.doi.org/10.1053/j.gastro.2010.11.003
7. Miranda A, Nordstrom E, Mannem A, Smith C, Banerjee B, Sengupta JN. The role of transient receptor potential vanilloid 1 in mechanical and chemical visceral hyperalgesia following experimental colitis. Neuroscience 2007; 148:1021-32; PMID:17719181; http://dx.doi.org/10.1016/j.neuroscience.2007.05.034
8. Perez-Burgos A, Wang L, McVey Neufeld K-A, Mao Y-K, Ahmadzai M, Janssen LJ, Stanisz AM, Bienenstock J, Kunze WA. The TRPV1 channel in rodents is a major target for antinociceptive effect of the probiotic Lactobacillus reuteri DSM 17938. J Physiol 2015; 593:3943-57; PMID:26084409; http://dx.doi.org/10.1113/JP270229
9. Zheng G, Wu SP, Hu Y, Smith DE, Wiley JW, Hong S. Corticosterone mediates stress-related increased intestinal permeability in a region-specific manner. Neurogastroenterol Motil 2013; 25:e127-39; PMID:23336591; http://dx.doi.org/10.1111/nmo.12066
10. Sun Y, Zhang M, Chen CC, Gillilland Iii M, Sun X, El–Zaatari M, Huffnagle GB, Young VB, Zhang J, Hong SC, et al. Stress-induced corticotropin-releasing hormone-mediated NLRP6 inflammasome inhibition and transmissible enteritis in Mice. Gastroenterology 2013; 144:1478-87.e8; PMID:23470617; http://dx.doi.org/10.1053/j.gastro.2013.02.038
11. Leng Y, Yi M, Fan J, Bai Y, Ge Q, Yao G. Effects of acute intra-abdominal hypertension on multiple intestinal barrier functions in rats. Sci Rep 2016; 6:22814; PMID:26980423
12. Lecomte V, Kaakoush NO, Maloney CA, Raipuria M, Huinao KD, Mitchell HM, Morris MJ. Changes in gut microbiota in Rats fed a high fat diet correlate with obesity-associated metabolic parameters. PLoS One 2015; 10:e0126931; PMID:25992554; http://dx.doi.org/10.1371/journal.pone.0126931
13. Cox-York KA, Sheflin AM, Foster MT, Gentile CL, Kahl A, Koch LG, Britton SL, Weir TL. Ovariectomy results in differential shifts in gut microbiota in low versus high aerobic capacity rats. Physiol Rep 2015:3:e12488 PMID:26265751; http://dx.doi.org/10.14814/phy2.12488
14. Jiang H, Ling Z, Zhang Y, Mao H, Ma Z, Yin Y, Wang W, Tang W, Tan Z, Shi J, et al. Altered fecal microbiota composition in patients with major depressive disorder. Brain, Behav Immun 2015; 48:186-94; PMID:25882912; http://dx.doi.org/10.1016/j.bbi.2015.03.016
15. Ponnusamy K, Choi JN, Kim J, Lee SY, Lee CH. Microbial community and metabolomic comparison of irritable bowel syndrome faeces. J Med Microbiol 2011; 60:817-27; PMID:21330412; http://dx.doi.org/10.1099/jmm.0.028126-0
16. Guarner F. The gut microbiome:what do we know? Clin Liver Dis 2015; 5:86-90; http://dx.doi.org/10.1002/cld.454
17. Le Chatelier E, Nielsen T, Qin J, Prifti E, Hildebrand F, Falony G, Almeida M, Arumugam M, Batto JM, Kennedy S, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500:541-6; PMID:23985870; http://dx.doi.org/10.1038/nature12506
18. Liang X, Bittinger K, Li X, Abernethy DR, Bushman FD, FitzGerald GA. Bidirectional interactions between indomethacin and the murine intestinal microbiota. eLife 2015; 4:e08973; PMID:26701907; http://dx.doi.org/10.7554/eLife.08973
19. Amir I, Konikoff FM, Oppenheim M, Gophna U, Half EE. Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors. Environ Microbiol 2014; 16:2905-14; PMID:24112768; http://dx.doi.org/10.1111/1462-2920.12285
20. Kelly DP, McDonald IR, Wood AP. The Family Methylobacteriaceae. In:Rosenberg E, DeLong EF, Lory S, Stackebrandt E, Thompson F, eds. The Prokaryotes:Alphaproteobacteria and Betaproteobacteria. Berlin, Heidelberg:Springer Berlin Heidelberg, 2014:313-40.
21. Kaakoush NO, Day AS, Huinao KD, Leach ST, Lemberg DA, Dowd SE, Mitchell HM. Microbial dysbiosis in pediatric patients with Crohn's disease. J Clin Microbiol 2012; 50:3258-66; PMID:22837318; http://dx.doi.org/10.1128/JCM.01396-12
22. Nelson TA, Holmes S, Alekseyenko AV, Shenoy M, Desantis T, Wu CH, Andersen GL, Winston J, Sonnenburg J, Pasricha PJ, et al. PhyloChip microarray analysis reveals altered gastrointestinal microbial communities in a rat model of colonic hypersensitivity. Neurogastroenterol Motil 2011; 23:169-77, e41-2.
23. Taverniti V, Guglielmetti S. Methodological issues in the study of intestinal microbiota in irritable bowel syndrome. World J Gastroenterol 2014; 20:8821-36; PMID:25083056
24. Xu D, Gao J, Gillilland Iii M, Wu X, Song I, Kao JY, Owyang C. Rifaximin alters intestinal bacteria and prevents stress-induced gut inflammation and visceral hyperalgesia in Rats. Gastroenterology 2014; 146:484-96.e4; PMID:24161699
25. Nell S, Suerbaum S, Josenhans C. The impact of the microbiota on the pathogenesis of IBD:lessons from mouse infection models. Nat Rev Micro 2010; 8:564-77; http://dx.doi.org/10.1038/nrmicro2403
26. Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS One 2013; 8:e71108; PMID:24013136; http://dx.doi.org/10.1371/journal.pone.0071108
27. Larsen N, Vogensen FK, van den Berg FWJ, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, Sørensen SJ, Hansen LH, Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS One 2010; 5:e9085; PMID:20140211; http://dx.doi.org/10.1371/journal.pone.0009085
28. Carroll IM, Ringel-Kulka T, Siddle JP, Ringel Y. Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea-predominant irritable bowel syndrome. Neurogastroenterol Motil 2012; 24:521-30; PMID:22339879; http://dx.doi.org/10.1111/j.1365-2982.2012.01891.x
29. Parthasarathy G, Chen J, Chen X, Chia N, O'Connor HM, Wolf PG, Gaskins HR, Bharucha AE. Relationship between microbiota of the colonic mucosa vs feces and symptoms, colonic transit, and methane production in female patients with chronic constipation. Gastroenterology 2016; 150:367-79.e1; PMID:26460205; http://dx.doi.org/10.1053/j.gastro.2015.10.005
30. Broadhurst MJ, Ardeshir A, Kanwar B, Mirpuri J, Gundra UM, Leung JM, Wiens KE, Vujkovic-Cvijin I, Kim CC, Yarovinsky F, et al. Therapeutic helminth infection of macaques with idiopathic chronic diarrhea alters the inflammatory signature and mucosal microbiota of the colon. PLoS Pathog 2012; 8:e1003000; PMID:23166490; http://dx.doi.org/10.1371/journal.ppat.1003000
31. Schaeffer AJ, Knauss JS, Landis JR, Propert KJ, Alexander RB, Litwin MS, Nickel JC, O'Leary MP, Nadler RB, Pontari MA, et al. Leukocyte and bacterial counts do not correlate with severity of symptoms in Men with chronic prostatitis:the national institutes of health chronic prostatitis cohort study. J Urol 2002; 168:1048-53; PMID:12187220; http://dx.doi.org/10.1016/S0022-5347(05)64572-7
32. Shoskes DA, Altemus J, Polackwich AS, Tucky B, Wang H, Eng C. The urinary microbiome differs significantly between patients with chronic prostatitis/chronic pelvic pain syndrome and controls as well as between patients with different clinical phenotypes. Urology 2016; 92:26-32; PMID:26970449
33. Urquhart DM, Zheng Y, Cheng AC, Rosenfeld JV, Chan P, Liew S, Hussain SM, Cicuttini FM. Could low grade bacterial infection contribute to low back pain? A systematic review. BMC Med 2015; 13:1-13; PMID:25609421; http://dx.doi.org/10.1186/s12916-015-0267-x
34. Derrien M, Belzer C, de Vos WM. Akkermansia muciniphila and its role in regulating host functions. Microbial Pathogenesis 2016; [Epub ahead of print] PMID:26875998; http://dx.doi.org/10.1016/j.micpath.2016.02.005
35. Plaza-Diaz J, Fernandez-Caballero JA, Chueca N, Garcia F, Gomez-Llorente C, Saez-Lara MJ, Fontana L, Gil Á. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains. Nutrients 2015; 7:3999-4015; PMID:26016655; http://dx.doi.org/10.3390/nu7063999
36. Kverka M, Zakostelska Z, Klimesova K, Sokol D, Hudcovic T, Hrncir T, Rossmann P, Mrazek J, Kopecny J, Verdu EF, et al. Oral administration of Parabacteroides distasonis antigens attenuates experimental murine colitis through modulation of immunity and microbiota composition. Clin Exp Immunol 2011; 163:250-9; PMID:21087444; http://dx.doi.org/10.1111/j.1365-2249.2010.04286.x
37. Tana C, Umesaki Y, Imaoka A, Handa T, Kanazawa M, Fukudo S. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22:512-9, e114-5.
38. Le Gall G, Noor SO, Ridgway K, Scovell L, Jamieson C, Johnson IT, Colquhoun IJ, Kemsley EK, Narbad A. Metabolomics of fecal extracts detects altered metabolic activity of gut microbiota in ulcerative colitis and irritable bowel syndrome. J Proteome Res 2011; 10:4208-18; PMID:21761941; http://dx.doi.org/10.1021/pr2003598
39. Jeffery IB, Claesson MJ, O'Toole PW. Intestinal microbiota, alterations in irritable bowel syndrome. In:Highlander SK, Rodriguez-Valera F, White BA, eds. Encyclopedia of Metagenomics:Environmental Metagenomics. Boston, MA:Springer US, 2015:295-9.
40. Major G, Spiller R. Irritable bowel syndrome, inflammatory bowel disease and the microbiome. Curr Opin Endocrinol Diabetes Obes 2014; 21:15-21; PMID:24296462; http://dx.doi.org/10.1097/MED.0000000000000032
41. Carbonero F, Benefiel AC, Alizadeh-Ghamsari AH, Gaskins HR. Microbial pathways in colonic sulfur metabolism and links with health and disease. Front Physiol 2012; 3:448; PMID:23226130; http://dx.doi.org/10.3389/fphys.2012.00448
42. Medani M, Collins D, Docherty NG, Baird AW, O'Connell PR, Winter DC. Emerging role of hydrogen sulfide in colonic physiology and pathophysiology. Inflammatory Bowel Dis 2011; 17:1620-5; PMID:21674719; http://dx.doi.org/10.1002/ibd.21528
43. Zheng G, Hong S, Hayes JM, Wiley JW. Chronic stress and peripheral pain:Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways. Exp Neurol 2015; 273:301-11; PMID:26408049; http://dx.doi.org/10.1016/j.expneurol.2015.09.013
44. Caporaso JG, Lauber CL, Walters WA, Berg-Lyons D, Lozupone CA, Turnbaugh PJ, Fierer N, Knight R. Global patterns of 16S rRNA diversity at a depth of millions of sequences per sample. Proc Natl Acad Sci U S A 2011; 108 Suppl 1:4516-22; PMID:20534432; http://dx.doi.org/10.1073/pnas.1000080107
45. McMurdie PJ, Holmes S. Waste not, want not:why rarefying microbiome data is inadmissible. PLoS Comput Biol 2014; 10:e1003531; PMID:24699258; http://dx.doi.org/10.1371/journal.pcbi.1003531
46. Good IJ. The population frequencies of species and the estimation of population parameters. Biometrika 1953; 40:237-64; http://dx.doi.org/10.1093/biomet/40.3-4.237
47. Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc 1963; 58:236-44; http://dx.doi.org/10.1080/01621459.1963.10500845
48. Abu-Asab MS, Chaouchi M, Alesci S, Galli S, Laassri M, Cheema AK, Atouf F, VanMeter J, Amri H. Biomarkers in the age of omics:time for a systems biology approach. OMICS 2011; 15:105-12; PMID:21319991; http://dx.doi.org/10.1089/omi.2010.0023
49. Myers AA, Giller P. Analytical biogeography:an integrated approach to the study of animal and plant distributions. Springer Science & Business Media, 2013.
50. Goloboff PA. Analyzing large data sets in reasonable times:solutions for composite optima. Cladistics 1999; 15:415-28; http://dx.doi.org/10.1111/j.1096-0031.1999.tb00278.x
51. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett W, Huttenhower C. Metagenomic biomarker discovery and explanation. Genome Biol 2011; 12:1-18; http://dx.doi.org/10.1186/gb-2011-12-S1-I1
52. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 2014; 15:550; PMID:25516281; http://dx.doi.org/10.1186/s13059-014-0550-8